We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.07B
AUM Growth
+$73.4M
Cap. Flow
-$4.19M
Cap. Flow %
-0.39%
Top 10 Hldgs %
69.02%
Holding
69
New
1
Increased
16
Reduced
4
Closed
3

Top Sells

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$6.14M
2
WFC icon
Wells Fargo
WFC
+$3.71M
3
BNY
Bank of New York Mellon
BNY
+$851K
4
KHC icon
Kraft Heinz
KHC
+$420K
5
BAC icon
Bank of America
BAC
+$91.1K

Sector Composition

Rank Sector Weight
1 Financials 45.24%
2 Healthcare 19.86%
3 Materials 6.83%
4 Industrials 6.41%
5 Technology 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAB icon
26
Wabtec
WAB
$50.3B
$6.59M 0.62%
71,523
BDX icon
27
Becton Dickinson
BDX
$49.4B
$6.03M 0.56%
24,569
FTV icon
28
Fortive
FTV
$18.6B
$5.39M 0.5%
93,753
+1,526
+2% +$86.2K
CI icon
29
Cigna
CI
$72.4B
$5.26M 0.49%
22,899
BA icon
30
Boeing
BA
$184B
$4.93M 0.46%
24,500
MA icon
31
Mastercard
MA
$492B
$3.59M 0.34%
10,000
HON icon
32
Honeywell
HON
$72.9B
$3.38M 0.32%
17,188
JKHY icon
33
Jack Henry & Associates
JKHY
$10.9B
$3.1M 0.29%
18,570
+3,770
+25% +$610K
VWO icon
34
Vanguard FTSE Emerging Markets ETF
VWO
$125B
$2.91M 0.27%
58,810
KO icon
35
Coca-Cola
KO
$372B
$2.87M 0.27%
48,400
LMT icon
36
Lockheed Martin
LMT
$138B
$2.53M 0.24%
7,120
+930
+15% +$322K
BMY icon
37
Bristol-Myers Squibb
BMY
$130B
$2.32M 0.22%
37,280
+10,830
+41% +$635K
CSCO icon
38
Cisco
CSCO
$475B
$2.25M 0.21%
35,500
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.11T
$2.21M 0.21%
7,390
AME icon
40
Ametek
AME
$58.8B
$2.05M 0.19%
13,930
+660
+5% +$90.3K
BAC icon
41
Bank of America
BAC
$448B
$1.99M 0.19%
44,740
-2,000
-4% -$91.1K
VHT icon
42
Vanguard Health Care ETF
VHT
$19B
$1.92M 0.18%
7,210
+2,790
+63% +$711K
MRK icon
43
Merck
MRK
$322B
$1.72M 0.16%
22,500
+3,340
+17% +$266K
VNT icon
44
Vontier
VNT
$4.61B
$1.72M 0.16%
56,086
AVXL icon
45
Anavex Life Sciences
AVXL
$325M
$1.48M 0.14%
85,585
GILD icon
46
Gilead Sciences
GILD
$168B
$1.35M 0.13%
18,630
STOR
47
DELISTED
STORE Capital Corporation
STOR
$1.26M 0.12%
36,700
UNP icon
48
Union Pacific
UNP
$174B
$1.03M 0.1%
4,080
PH icon
49
Parker-Hannifin
PH
$134B
$903K 0.08%
2,840
+590
+26% +$182K
BTI icon
50
British American Tobacco
BTI
$122B
$885K 0.08%
23,650

Similar funds

Hikari Power's Q4 2021 Portfolio in Review

As of Q4 2021, Hikari Power held 69 positions worth $1.07B, up 7.4% from $997M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Hikari Power's Q4 2021 filing shows 1 new, 16 increased, 4 reduced and 3 closed positions. Its largest new stake was Ocular Therapeutix: 12,000 shares worth $84K. The largest sale was AB InBev, an estimated $6.14M.

By sector, the portfolio is most concentrated in Financials at 45% of assets, down from 46% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power's largest Q4 2021 buy was Ocular Therapeutix: 12,000 shares worth $84K.
  • Hikari Power added most to Altria Group in Q4 2021, an estimated $2M increase.
  • Hikari Power's biggest Q4 2021 reduction was Wells Fargo, cutting an estimated $3.71M.
  • Hikari Power fully exited AB InBev in Q4 2021, selling an estimated $6.14M.
  • Hikari Power's ten largest holdings make up 69% of its $1.07B portfolio in Q4 2021.
  • Hikari Power opened 1 new position and closed 3 in Q4 2021.
  • Hikari Power's portfolio value rose 7.4% quarter-over-quarter to $1.07B.

Based on Hikari Power's 13F filing for Q4 2021, filed 12 Jan 2022.